The DOI matches its Crossref record; 552 of the 552 references it cites were found in a registry or an index.
Chemical and Biomolecular Strategies for STING Pathway Activation in Cancer Immunotherapy
Open accessAbstract
The stimulator of interferon genes (STING) cellular signaling pathway is a promising target for cancer immunotherapy. Activation of the intracellular STING protein triggers the production of a multifaceted array of immunostimulatory molecules, which, in the proper context, can drive dendritic cell maturation, antitumor macrophage polarization, T cell priming and activation, natural killer cell activation, vascular reprogramming, and/or cancer cell death, resulting in immune-mediated tumor elimination and generation of antitumor immune memory. Accordingly, there is a significant amount of ongoing preclinical and clinical research toward further understanding the role of the STING pathway in cancer immune surveillance as well as the development of modulators of the pathway as a strategy to stimulate antitumor immunity. Yet, the efficacy of STING pathway agonists is limited by many drug delivery and pharmacological challenges. Depending on the class of STING agonist and the desired administration route, these may include poor drug stability, immunocellular toxicity, immune-related adverse events, limited tumor or lymph node targeting and/or retention, low cellular uptake and intracellular delivery, and a complex dependence on the magnitude and kinetics of STING signaling. This review provides a concise summary of the STING pathway, highlighting recent biological developments, immunological consequences, and implications for drug delivery. This review also offers a critical analysis of an expanding arsenal of chemical strategies that are being employed to enhance the efficacy, safety, and/or clinical utility of STING pathway agonists and lastly draws attention to several opportunities for therapeutic advancements.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Items 401–552 of 552
Huang, L., Li, L., Lemos, H. D. P., Chandler, P., Pacholczyk, G. A., Baban, B., Barber, G. N., Hayakawa, Y., McGaha, T. L., Ravishankar, B., et al. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1301419 · Cited by 128
Recognition of cytosolic DNA by c GAS and other STING ‐dependent sensors
Bhat, N., & Fitzgerald, K. A. (2013) · European Journal of Immunology · doi:10.1002/eji.201344127 · Cited by 127
Connexin43 acts as a colorectal cancer tumor suppressor and predicts disease outcome
Sirnes, S., Bruun, J., Kolberg, M., Kjenseth, A., Lind, G. E., Svindland, A., Brech, A., Nesbakken, A., Lothe, R. A., Leithe, E., et al. (2011) · International Journal of Cancer · doi:10.1002/ijc.26392 · Cited by 127
Identification and characterization of a loss-of-function human MPYS variant
Jin, L., Xu, L., Yang, I. V., Davidson, E. J., Schwartz, D. A., Wurfel, M. M., & Cambier, J. C. (2011) · Genes and Immunity · doi:10.1038/gene.2010.75 · Cited by 127
Sali, T. M., Pryke, K. M., Abraham, J., Liu, A., Archer, I., Broeckel, R. M., Staverosky, J. A., Smith, J. L., Al-Shammari, A. M., Amsler, L., et al. (2015) · PLoS Pathogens · doi:10.1371/journal.ppat.1005324 · Cited by 127
ALK is a therapeutic target for lethal sepsis
Zeng, L., Kang, R., Zhu, S., Wang, X., Cao, L., Wang, H., Billiar, T. R., Jiang, J., & Tang, D. (2017) · Science Translational Medicine · doi:10.1126/scitranslmed.aan5689 · Cited by 126
cGAS-mediated autophagy protects the liver from ischemia-reperfusion injury independently of STING
Lei, Z., Deng, M., Yi, Z., Sun, Q., Shapiro, R. A., Xu, H., Li, T., Loughran, P., Griepentrog, J. E., Huang, H., et al. (2018) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00326.2017 · Cited by 125
ENPP1, an Old Enzyme with New Functions, and Small Molecule Inhibitors—A STING in the Tale of ENPP1
Onyedibe, K. I., Wang, M., & Sintim, H. O. (2019) · Molecules · doi:10.3390/molecules24224192 · Cited by 125
Chromatin bridges, not micronuclei, activate cGAS after drug-induced mitotic errors in human cells
Flynn, P. J., Koch, P. D., & Mitchison, T. J. (2021) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2103585118 · Cited by 125
Liu, Y., Wang, L., Song, Q., Ali, M., Crowe, W. N., Kucera, G. L., Hawkins, G. A., Söker, S., Thomas, K. W., Miller, L. D., et al. (2021) · Nature Nanotechnology · doi:10.1038/s41565-021-01032-w · Cited by 125
Lohard, S., Bourgeois, N., Maillet, L., Gautier, F., Fétiveau, A., Lasla, H., Nguyen, F., Vuillier, C., Dumont, A., Moreau‐Aubry, A., et al. (2020) · Nature Communications · doi:10.1038/s41467-019-13689-y · Cited by 123
Molecular Biology and Physiology of Volume-Regulated Anion Channel (VRAC)
Osei‐Owusu, J., Yang, J., Vitery, M. D. C., & Qiu, Z. (2018) · Current topics in membranes · doi:10.1016/bs.ctm.2018.07.005 · Cited by 120
Tse, S., McKinney, K. M., Walker, W., Nguyen, M., Iacovelli, J., Small, C. G., Hopson, K., Zaks, T. Z., & Huang, E. (2021) · Molecular Therapy · doi:10.1016/j.ymthe.2021.03.002 · Cited by 119
Radvanyi, Banerjee, Weir, & Messner (1999) · Scandinavian Journal of Immunology · doi:10.1046/j.1365-3083.1999.00625.x · Cited by 118
In situ cancer vaccination using lipidoid nanoparticles
Chen, J., Qiu, M., Ye, Z., Li, Y., Li, Y., Glass, Z., Zhao, X., Yang, L., Chen, J., & Xu, Q. (2021) · Science Advances · doi:10.1126/sciadv.abf1244 · Cited by 118
cGAS activation causes lupus-like autoimmune disorders in a TREX1 mutant mouse model
Xiao, N., Wei, J., Xu, S., Du, H., Huang, M., Zhang, S., Ye, W., Sun, L., & Chen, Q. (2019) · Journal of Autoimmunity · doi:10.1016/j.jaut.2019.03.001 · Cited by 117
Kim, D., Endo, A., Fang, F. G., Huang, K., Bao, X., Choi, H.-W., Majumder, U., Shen, Y., Mathieu, S. R., Zhu, X., et al. (2021) · ChemMedChem · doi:10.1002/cmdc.202100068 · Cited by 113
Allosteric coupling between Mn2+ and dsDNA controls the catalytic efficiency and fidelity of cGAS
Hooy, R. M., Massaccesi, G., Rousseau, K. E., Chattergoon, M. A., & Sohn, J. (2020) · Nucleic Acids Research · doi:10.1093/nar/gkaa084 · Cited by 112
Stimulator of interferon genes (STING) activation exacerbates experimental colitis in mice
Martin, G. R., Blomquist, C. M., Henare, K. L., & Jirik, F. R. (2019) · Scientific Reports · doi:10.1038/s41598-019-50656-5 · Cited by 111
Fang, C., Mo, F., Liu, L., Du, J., Luo, M., Men, K., Na, F., Wang, W., Yang, H., & Wei, X. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-0456-1 · Cited by 111
Dawn of lipid nanoparticles in lymph node targeting: Potential in cancer immunotherapy
Nakamura, T., & Harashima, H. (2020) · Advanced Drug Delivery Reviews · doi:10.1016/j.addr.2020.06.003 · Cited by 110
Gao, P., Zillinger, T., Wang, W., Ascano, M., Dai, P., Hartmann, G., Tuschl, T., Deng, L., Barchet, W., & Patel, D. J. (2014) · Cell Reports · doi:10.1016/j.celrep.2014.08.010 · Cited by 109
Philpott, M., Baguley, B. C., & Ching, L. (1995) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00689199 · Cited by 108
Gou, S., Liu, W., Wang, S., Chen, G., Chen, Z., Qiu, L., Zhou, X., Wu, Y., Qi, Y., & Gao, Y. (2021) · Nano Letters · doi:10.1021/acs.nanolett.1c03243 · Cited by 108
STING in tumor and host cells cooperatively work for NK cell-mediated tumor growth retardation
Takashima, K., Takeda, Y., Oshiumi, H., Shime, H., Okabe, M., Ikawa, M., Matsumoto, M., & Seya, T. (2016) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2016.09.021 · Cited by 106
Luthra, P., Aguirre, S., Yen, B. C., Pietzsch, C. A., Sánchez-Aparicio, M. T., Tigabu, B., Morlock, L., García‐Sastre, A., Leung, D. W., Williams, N. S., et al. (2017) · mBio · doi:10.1128/mbio.00368-17 · Cited by 106
A 30-year journey from volume-regulated anion currents to molecular structure of the LRRC8 channel
Strange, K. B., Yamada, T., & Denton, J. S. (2019) · The Journal of General Physiology · doi:10.1085/jgp.201812138 · Cited by 105
The binding of TBK1 to STING requires exocytic membrane traffic from the ER
Ogawa, E., Mukai, K., Saito, K., Arai, H., & Taguchi, T. (2018) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2018.05.199 · Cited by 103
A STING to inflammation and autoimmunity
Kumar, V. (2019) · Journal of Leukocyte Biology · doi:10.1002/jlb.4mir1018-397rr · Cited by 102
Shi, H., Wu, J., Chen, Z. J., & Chen, C. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1507317112 · Cited by 101
A Nanoprimer To Improve the Systemic Delivery of siRNA and mRNA
Saunders, N., Paolini, M. S., Fenton, O. S., Poul, L., Devallière, J., Mpambani, F., Darmon, A., Bergère, M., Jibault, O., Germain, M., et al. (2020) · Nano Letters · doi:10.1021/acs.nanolett.0c00752 · Cited by 100
Recent progress in mitochondria-targeting-based nanotechnology for cancer treatment
Qin, J., Gong, N., Liao, Z., Zhang, S., Timashev, P. S., Huo, S., & Liang, X. (2021) · Nanoscale · doi:10.1039/d1nr01068a · Cited by 100
Dynamic Structural Differences between Human and Mouse STING Lead to Differing Sensitivity to DMXAA
Shih, A. Y., Damm‐Ganamet, K. L., & Mirzadegan, T. (2018) · Biophysical Journal · doi:10.1016/j.bpj.2017.10.027 · Cited by 99
In situ activation of STING pathway with polymeric SN38 for cancer chemoimmunotherapy
Zhao, J., Ma, S., Xu, Y., Si, X., Yao, H., Huang, Z., Zhang, Y., Yu, H., Tang, Z., Song, W., et al. (2020) · Biomaterials · doi:10.1016/j.biomaterials.2020.120542 · Cited by 99
Sun, L., Funchain, P., Song, J. M., Rayman, P. A., Tannenbaum, C. S., Ko, J. S., McNamara, M. J., Diaz-Montero, C. M., & Gastman, B. (2018) · Journal for ImmunoTherapy of Cancer · doi:10.1186/s40425-018-0337-7 · Cited by 98
Luo, M., Liu, Z., Zhang, X., Han, C., Samandi, L. Z., Dong, C., Sumer, B. D., Lea, J. S., Fu, Y., & Gao, J. (2019) · Journal of Controlled Release · doi:10.1016/j.jconrel.2019.02.036 · Cited by 98
The STING ligand cGAMP potentiates the efficacy of vaccine-induced CD8+ T cells
Gutjahr, A., Papagno, L., Nicoli, F., Kanuma, T., Kuse, N., Cabral-Piccin, M. P., Rochereau, N., Emma Gostick, D., Lioux, T., Pérouzel, É., et al. (2019) · JCI Insight · doi:10.1172/jci.insight.125107 · Cited by 98
García, N., & Chávez, E. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.08.019 · Cited by 97
An, M., Yu, C., Xi, J., Reyes, J. D., Mao, G., Wei, W., & Liu, H. (2018) · Nanoscale · doi:10.1039/c8nr01376d · Cited by 97
Das, M., Shen, L., Liu, Q., Goodwin, T. J., & Huang, L. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.11.012 · Cited by 97
Interferon-γ mediates chemokine-dependent recruitment of natural killer cells during viral infection
Pak-Wittel, M. A., Yang, L., Sojka, D. K., Rivenbark, J. G., & Yokoyama, W. M. (2012) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1220456110 · Cited by 95
Flavone acetic acid (NSC 347512) induces haemorrhagic necrosis of mouse colon 26 and 38 tumours
Smith, G. P., Calveley, S. B., Smith, M. J., & Baguley, B. C. (1987) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(87)90157-x · Cited by 95
Interferon-α as angiogenesis inhibitor: Learning from tumor models
Indraccolo, S. (2010) · Autoimmunity · doi:10.3109/08916930903510963 · Cited by 94
A perspective on the clinical effectiveness and tolerance of interferon-alpha.
Borden, E. C., & Parkinson, D. (1998) · PubMed · Cited by 94
Identification of α‐Mangostin as an Agonist of Human STING
Zhang, Y., Sun, Z., Pei, J., Luo, Q., Zeng, X. Y., Li, Q., Yang, Z., & Quan, J. (2018) · ChemMedChem · doi:10.1002/cmdc.201800481 · Cited by 94
McKeage, M. J., Reck, M., Jameson, M. B., Rosenthal, M. A., Gibbs, D. D., Mainwaring, P. N., Freitag, L., Sullivan, R., & von Pawel, J. (2009) · Lung Cancer · doi:10.1016/j.lungcan.2009.03.027 · Cited by 93
McAndrews, K. M., Che, S. P. Y., LeBleu, V. S., & Kalluri, R. (2021) · Journal of Biological Chemistry · doi:10.1016/j.jbc.2021.100523 · Cited by 93
Hepatic gap junctions amplify alcohol liver injury by propagating cGAS-mediated IRF3 activation
Luther, J., Khan, S. K., Gala, M. K., Kedrin, D., Sridharan, G. V., Goodman, R. P., Garber, J. J., Masia, R., Diagacomo, E., Adams, D. J., et al. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1911870117 · Cited by 92
Regulation and Consequences of cGAS Activation by Self-DNA
Zierhut, C., & Funabiki, H. (2020) · Trends in Cell Biology · doi:10.1016/j.tcb.2020.05.006 · Cited by 91
Factors affecting the pharmacokinetics and pharmacodynamics of liposomal drugs
Song, G. K., Wu, H., Yoshino, K., & Zamboni, W. C. (2012) · Journal of Liposome Research · doi:10.3109/08982104.2012.655285 · Cited by 90
Therapeutic Activity of High-Dose Intratumoral IFN-β Requires Direct Effect on the Tumor Vasculature
Spaapen, R. M., Leung, M. Y. K., Fuertes, M. B., Kline, J. P., Zhang, L., Zheng, Y., Fu, Y., Luo, X., Cohen, K. S., & Gajewski, T. F. (2014) · The Journal of Immunology · doi:10.4049/jimmunol.1401109 · Cited by 89
Induction of type I IFNs by intracellular DNA‐sensing pathways
Cavlar, T., Ablasser, A., & Hornung, V. (2012) · Immunology and Cell Biology · doi:10.1038/icb.2012.11 · Cited by 88
Natural STING Agonist as an “Ideal” Adjuvant for Cutaneous Vaccination
Wang, J., Li, P., & Wu, M. X. (2016) · Journal of Investigative Dermatology · doi:10.1016/j.jid.2016.05.105 · Cited by 86
DNA Methyltransferase Inhibitors: Catalysts For Antitumour Immune Responses
Dan, H., Zhang, S., Zhou, Y., & Guan, Q. (2019) · OncoTargets and Therapy · doi:10.2147/ott.s217767 · Cited by 86
STING Signaling in Cancer Cells: Important or Not?
Sokołowska, O., & Nowis, D. (2017) · Archivum Immunologiae et Therapiae Experimentalis · doi:10.1007/s00005-017-0481-7 · Cited by 85
Eisel, D., Das, K., Dickes, E., König, R., Osen, W., & Eichmüller, S. B. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00219 · Cited by 84
Zheng, Z., Jia, S., Shao, C., & Shi, Y. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2546-5 · Cited by 84
Lukaszewski, R. A., & Brooks, T. J. G. (2000) · Journal of Virology · doi:10.1128/jvi.74.11.5006-5015.2000 · Cited by 83
Nakaya, Y., Lilue, J., Stavrou, S., Moran, E. A., & Ross, S. R. (2017) · mBio · doi:10.1128/mbio.00944-17 · Cited by 83
Atukorale, P. U., Raghunathan, S. P., Raguveer, V., Moon, T. J., Zheng, C., Bielecki, P. A., Wiese, M. L., Goldberg, A. L., Covarrubias, G., Hoimes, C. J., et al. (2019) · Cancer Research · doi:10.1158/0008-5472.can-19-0381 · Cited by 83
Hall, J., Ralph, E. C., Shanker, S., Wang, H., Byrnes, L. J., Horst, R., Wong, J., Brault, A. L., Dumlao, D. S., Smith, J. F., et al. (2017) · Protein Science · doi:10.1002/pro.3304 · Cited by 81
Fentahun Darge, H., Yibru Hanurry, E., Simegniew Birhan, Y., Worku Mekonnen, T., Tizazu Andrgie, A., Chou, H.-Y., Lai, J.-Y., & Tsai, H.-C. (2021) · Chemical Engineering Journal · doi:10.1016/j.cej.2020.126879 · Cited by 81
Multifunctional STING‐Activating Mn3O4@Au‐dsDNA/DOX Nanoparticle for Antitumor Immunotherapy
Zhou, M., Wang, X., Lin, S., Cheng, Y., Zhao, S., Lin, J., Fang, Z., Lou, Z., Qin, L., & Wei, H. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202000064 · Cited by 80
Chen, Y., Xu, L., Tang, T.-W., Chen, C.-H., Zheng, Q.-H., Liu, T., Mou, C., Wu, C.-H., & Wu, S. (2020) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.0c16728 · Cited by 79
Enpp1: A Potential Facilitator of Breast Cancer Bone Metastasis
Lau, W. M., Doucet, M., Stadel, R. P., Huang, D. C. S., WEBER, K. L., & Kominsky, S. L. (2013) · PLoS ONE · doi:10.1371/journal.pone.0066752 · Cited by 77
cGAS facilitates sensing of extracellular cyclic dinucleotides to activate innate immunity
Liu, H., Moura‐Alves, P., Pei, G., Mollenkopf, H., HURWITZ, R. M., Wu, X., Wang, F., Liu, S., Ma, M., Fei, Y., et al. (2019) · EMBO Reports · doi:10.15252/embr.201846293 · Cited by 77
The allosteric activation of cGAS underpins its dynamic signaling landscape
Hooy, R. M., & Sohn, J. (2018) · eLife · doi:10.7554/elife.39984 · Cited by 76
TREX1 as a Novel Immunotherapeutic Target
Hemphill, W. O., Simpson, S. R., Liu, M., Salsbury, F. R., Hollis, T., Grayson, J. M., & Perrino, F. W. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.660184 · Cited by 76
Flavone acetic acid—Preclinical and clinical activity
Kerr, D. J., & Kaye, S. B. (1989) · European Journal of Cancer and Clinical Oncology · doi:10.1016/0277-5379(89)90072-2 · Cited by 74
New perspectives on type I IFNs in cancer
Gajewski, T. F., & Corrales, L. P. (2015) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2015.01.001 · Cited by 74
A cell-based high throughput screening assay for the discovery of cGAS-STING pathway agonists
Liu, B., Tang, L., Zhang, X., Ma, J., Sehgal, M., Cheng, J., Zhang, X., Zhou, Y., Du, Y., Kulp, J. L., et al. (2017) · Antiviral Research · doi:10.1016/j.antiviral.2017.10.001 · Cited by 74
Cytosolic Delivery of Thiolated Mn‐cGAMP Nanovaccine to Enhance the Antitumor Immune Responses
Chen, C., Tong, Y., Zheng, Y., Shi, Y., Chen, Z., Li, J., Liu, X., Zhang, D., & Yang, H. (2021) · Small · doi:10.1002/smll.202006970 · Cited by 74
Chitosan: An Adjuvant with an Unanticipated STING
Riteau, N., & Sher, A. (2016) · Immunity · doi:10.1016/j.immuni.2016.03.002 · Cited by 73
A Manganese Phosphate Nanocluster Activates the cGAS‐STING Pathway for Enhanced Cancer Immunotherapy
Gao, M., Xie, Y., Lei, K., Zhao, Y., Kurum, A., Herck, S. V., Guo, Y., Hu, X., & Tang, L. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100065 · Cited by 73
Human and Mouse IFN-β Gene Therapy Exhibits Different Anti-tumor Mechanisms in Mouse Models
Qin, X.-Q., Beckham, C. J., Brown, J. L., Lukashev, M., & Barsoum, J. (2001) · Molecular Therapy · doi:10.1006/mthe.2001.0464 · Cited by 72
Digital signaling network drives the assembly of the AIM2-ASC inflammasome
Matyszewski, M., Morrone, S. R., & Sohn, J. (2018) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1712860115 · Cited by 72
Yang, X., Yang, Y., Bian, J., Wei, J., Wang, Z., Zhou, Z., Li, Z., & Sun, M. (2021) · Nano Today · doi:10.1016/j.nantod.2021.101109 · Cited by 72
Synthesis and immunostimulatory properties of the phosphorothioate analogues of cdiGMP
Yan, H., Wang, X., KuoLee, R., & Chen, W. (2008) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2008.08.088 · Cited by 70
What, Why, Where, and When: Bringing Timing to Immuno-Oncology
Rothschilds, A. M., & Wittrup, K. D. (2018) · Trends in Immunology · doi:10.1016/j.it.2018.11.003 · Cited by 70
Self-DNA Sensing in Lung Inflammatory Diseases
Benmerzoug, S., Ryffel, B., Togbe, D., & Quesniaux, V. F. J. (2019) · Trends in Immunology · doi:10.1016/j.it.2019.06.001 · Cited by 70
Connexin-Dependent Transfer of cGAMP to Phagocytes Modulates Antiviral Responses
Pépin, G., Nardo, D. D., Rootes, C. L., Ullah, T. R., Al-Asmari, S. S., Balka, K. R., Li, H., Quinn, K. M., Moghaddas, F., Chappaz, S., et al. (2020) · mBio · doi:10.1128/mbio.03187-19 · Cited by 70
STING Signaling Promotes Apoptosis, Necrosis, and Cell Death: An Overview and Update
Liu, S., & Guan, W. (2018) · Mediators of Inflammation · doi:10.1155/2018/1202797 · Cited by 69
More than just a pressure relief valve: physiological roles of volume-regulated LRRC8 anion channels
Chen, L., König, B., Liu, T., Pervaiz, S., Razzaque, Y. S., & Stauber, T. (2019) · Biological Chemistry · doi:10.1515/hsz-2019-0189 · Cited by 69
Baranovskii, A. G., Buneva, V. N., & Nevinsky, G. A. (2004) · Biochemistry (Moscow) · doi:10.1023/b:biry.0000033731.50496.01 · Cited by 69
Xi, Q., Wang, M., Jia, W., Yang, M., Hu, J., Jin, J., Chen, X., Yin, D., & Wang, X. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01567 · Cited by 67
Cyclic GMP-AMP Displays Mucosal Adjuvant Activity in Mice
Škrnjug, I., Guzmán, C. A., & Ruecker, C. (2014) · PLoS ONE · doi:10.1371/journal.pone.0110150 · Cited by 65
DMXAA: An antivascular agent with multiple host responses
Baguley, B. C., & Ching, L. (2002) · International Journal of Radiation Oncology*Biology*Physics · doi:10.1016/s0360-3016(02)03920-2 · Cited by 64
Can innate immune system targets turn up the heat on 'cold' tumours?
Mullard, A. (2017) · Nature Reviews Drug Discovery · doi:10.1038/nrd.2017.264 · Cited by 64
Walker, M. M., Crute, B. W., Cambier, J. C., & Getahun, A. (2018) · The Journal of Immunology · doi:10.4049/jimmunol.1701405 · Cited by 63
Immunostimulatory silica nanoparticle boosts innate immunity in brain tumors
Bielecki, P. A., Lorkowski, M. E., Becicka, W. M., Atukorale, P. U., Moon, T. J., Zhang, Y., Wiese, M. L., Covarrubias, G., Ravichandran, S., & Karathanasis, E. (2020) · Nanoscale Horizons · doi:10.1039/d0nh00446d · Cited by 62
Self-assembled cGAMP-STINGΔTM signaling complex as a bioinspired platform for cGAMP delivery
He, Y., Hong, C., Yan, E. Z., Fletcher, S. J., Zhu, G., Yang, M., Li, Y., Sun, X., Irvine, D. J., Li, J., et al. (2020) · Science Advances · doi:10.1126/sciadv.aba7589 · Cited by 60
Lorkowski, M. E., Atukorale, P. U., Bielecki, P. A., Tong, K.-K., Covarrubias, G., Zhang, Y., Loutrianakis, G., Moon, T. J., Santulli, A. R., Becicka, W. M., et al. (2020) · Journal of Controlled Release · doi:10.1016/j.jconrel.2020.11.014 · Cited by 59
Impacts of PEGylation on the gene and oligonucleotide delivery system
Ikeda, Y., & Nagasaki, Y. (2013) · Journal of Applied Polymer Science · doi:10.1002/app.40293 · Cited by 58
Yan, S., Shen, H., Lian, Q., Jin, W., Zhang, R., Lin, X., Gu, W., Sun, X., Meng, G., Tian, Z., et al. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1701177 · Cited by 55
Orebaugh, C. D., Fye, J. M., Harvey, S. E., Hollis, T., & Perrino, F. W. (2011) · Journal of Biological Chemistry · doi:10.1074/jbc.m111.297903 · Cited by 54
The promiscuous ectonucleotidase NPP1: molecular insights into substrate binding and hydrolysis
Namasivayam, V., Lee, S.-Y., & Müller, C. E. (2016) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2016.12.019 · Cited by 52
Xu, S., Ducroux, A., Ponnurangam, A., Vièyres, G., Franz, S., Müsken, M., Zillinger, T., Malassa, A., Ewald, E., Hornung, V., et al. (2016) · Cell Host & Microbe · doi:10.1016/j.chom.2016.09.003 · Cited by 51
Topoisomerase 1 Inhibition Promotes Cyclic GMP-AMP Synthase-Dependent Antiviral Responses
Pépin, G., Nejad, C., Ferrand, J., Thomas, B. J., Stunden, H. J., Sanij, E., Foo, C. H., Stewart, C. R., Cain, J. E., Bardin, P. G., et al. (2017) · mBio · doi:10.1128/mbio.01611-17 · Cited by 50
Lee, E. H., Jang, H.-E., Kang, Y. Y., Kim, J., Ahn, J., & Mok, H. (2015) · Acta Biomaterialia · doi:10.1016/j.actbio.2015.10.025 · Cited by 49
Vyskočil, Š., Cardin, D., Ciavarri, J. P., Conlon, J., Cullis, C. A., England, D. B., Gershman, R. E., Gigstad, K. M., Gipson, K., Gould, A. E., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00374 · Cited by 49
Structural basis for overhang excision and terminal unwinding of DNA duplexes by TREX1
Huang, K.-W., Liu, T.-C., Liang, R.-Y., Chu, L.-Y., Cheng, H.-L., Chu, J., & Hsiao, Y.-Y. (2018) · PLoS Biology · doi:10.1371/journal.pbio.2005653 · Cited by 48
STING regulates BCR signaling in normal and malignant B cells
Tang, C.-H. A., Lee, A. C., Chang, S., Xu, Q. S., Shao, A., Lo, Y., Spalek, W. T., Pinilla-Ibarz, J. A., Valle, J. R. D., & Hu, C. A. (2020) · Cellular and Molecular Immunology · doi:10.1038/s41423-020-00552-0 · Cited by 48
Polidarova, M. P., Břehová, P., Kaiser, M. M., Smola, M., Dračínský, M., Smith, J., Marek, A., Dejmek, M., Šála, M., Gutten, O., et al. (2021) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.1c00301 · Cited by 48
Turley, J. L., Moran, H. B. T., McEntee, C. P., O’Grady, K., Muñoz‐Wolf, N., Jin, L., Follmann, F., Andersen, P. L., Andersson, M., & Lavelle, E. C. (2021) · Biomaterials · doi:10.1016/j.biomaterials.2021.120961 · Cited by 48
Li, K., Ye, Y., Liu, L., Sha, Q., Wang, X., Jiao, T., Zhang, L., & Wang, J. (2020) · Biomaterials Science · doi:10.1039/d0bm00870b · Cited by 47
Temporally Programmed CD8α+ DC Activation Enhances Combination Cancer Immunotherapy
Tzeng, A., Kauke, M. J., Zhu, E. F., Moynihan, K. D., Opel, C. F., Yang, N. J., Mehta, N. K., Kelly, R. L., Szeto, G. L., Overwijk, W. W., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.11.020 · Cited by 46
Ubiquitination of cGAS by TRAF6 regulates anti-DNA viral innate immune responses
Chen, X., & Chen, Y. (2019) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2019.05.022 · Cited by 46
Park, K. S., Xu, C., Sun, X., Louttit, C., & Moon, J. J. (2020) · Advanced Therapeutics · doi:10.1002/adtp.202000130 · Cited by 46
Human B cells fail to secrete type I interferons upon cytoplasmic DNA exposure
Gram, A. M., Sun, C., Landman, S. L., Oosenbrug, T., Koppejan, H., Kwakkenbos, M. J., Hoeben, R. C., Paludan, S. R., & Ressing, M. E. (2017) · Molecular Immunology · doi:10.1016/j.molimm.2017.08.025 · Cited by 45
Increased vaccine tolerability and protection via NF-κB modulation
Moser, B., Steinhardt, R. C., Escalante-Buendia, Y., Boltz, D. A., Barker, K., Cassaidy, B., Rosenberger, M. G., Yoo, S., McGonnigal, B., & Esser-Kahn, A. P. (2020) · Science Advances · doi:10.1126/sciadv.aaz8700 · Cited by 45
The mechanism of the anticancer function of M1 macrophages and their use in the clinic
Pan, X.-Q. (2012) · 癌症:英文版 · doi:10.5732/cjc.012.10046 · Cited by 44
cGAS-independent STING activation in response to DNA damage
Unterholzner, L., & Dunphy, G. (2019) · Molecular & Cellular Oncology · doi:10.1080/23723556.2018.1558682 · Cited by 42
Translation of combination nanodrugs into nanomedicines: lessons learned and future outlook
Mu, Q., Yu, J., McConnachie, L. A., Kraft, J. C., Gao, Y., Gulati, G. K., & Ho, R. J. Y. (2017) · Journal of drug targeting · doi:10.1080/1061186x.2017.1419363 · Cited by 40
Kawaguchi, M., Han, X. F., Hisada, T., Nishikawa, S., Kano, K., Ieda, N., Aoki, J., Toyama, T., & Nakagawa, H. (2019) · Journal of Medicinal Chemistry · doi:10.1021/acs.jmedchem.9b01213 · Cited by 39
Inclusion of cGAMP within virus-like particle vaccines enhances their immunogenicity
Chauveau, L., Bridgeman, A., Tan, T. K., Beveridge, R. D. D., Frost, J. N., Rijal, P., Pedroza‐Pacheco, I., Partridge, T., Gilbert‐Jaramillo, J., Knight, M. L., et al. (2021) · EMBO Reports · doi:10.15252/embr.202152447 · Cited by 39
Lemos, H. D. P., Huang, L., McGaha, T. L., & Mellor, A. L. (2014) · European Journal of Immunology · doi:10.1002/eji.201344407 · Cited by 38
Miyake, K., Shibata, T., Ohto, U., & Shimizu, T. (2016) · Journal of Leukocyte Biology · doi:10.1189/jlb.4mr0316-108r · Cited by 38
Karayel, E., Bürckstümmer, T., Bilban, M., Dürnberger, G., Weitzer, S., Martinez, J., & Superti‐Furga, G. (2009) · European Journal of Immunology · doi:10.1002/eji.200939344 · Cited by 36
G10 is a direct activator of human STING
Banerjee, M., Middya, S., Shrivastava, R., Basu, S., Ghosh, R., Pryde, D. C., Yadav, D. B., & Surya, A. (2020) · PLoS ONE · doi:10.1371/journal.pone.0237743 · Cited by 35
Zandberg, D. P., Ferris, R. L., Laux, D. E., Mehra, R., Nabell, L. M., Kaczmar, J. M., Gibson, M. K., Kim, Y. J., Neupane, P., Bauman, J. E., et al. (2020) · Annals of Oncology · doi:10.1016/j.annonc.2020.10.559 · Cited by 34
Balancing STING in antimicrobial defense and autoinflammation
Landman, S. L., Ressing, M. E., & van der Veen, A. G. (2020) · Cytokine & Growth Factor Reviews · doi:10.1016/j.cytogfr.2020.06.004 · Cited by 33
Lu, Z.-D., Chen, Y., Shen, S., Xu, C., & Wang, J. (2021) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.1c08329 · Cited by 33
Macro-nanomedicine: Targeting the big picture
Lammers, T. (2018) · Journal of Controlled Release · doi:10.1016/j.jconrel.2018.11.031 · Cited by 32
Streptavidin Promotes DNA Binding and Activation of cGAS to Enhance Innate Immunity
Zhang, Y., Ma, Z., Wang, Y., Boyer, J. A., Ni, G., Cheng, L., Su, S., Zhang, Z., Zhu, Z., Qian, J., et al. (2020) · iScience · doi:10.1016/j.isci.2020.101463 · Cited by 32
Liu, L., Liu, Y., Xu, B., Liu, C., Jia, Y., Liu, T., Fang, C., Wang, W., Ren, J., He, Z., et al. (2018) · Theranostics · doi:10.7150/thno.21693 · Cited by 31
Shakya, A. K., Lee, C. H., Uddin, M. J., & Gill, H. S. (2018) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.8b00768 · Cited by 31
Xu, J., Zoltick, P. W., Gamero, A. M., & Gallucci, S. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.2a0713-393rr · Cited by 30
Tiered DNA sensors for escalating responses
Emming, S., & Schroder, K. (2019) · Science · doi:10.1126/science.aay2701 · Cited by 30
The innate immune DNA sensor cGAS: A membrane, cytosolic, or nuclear protein?
Gekara, N. O., & Jiang, H. (2019) · Science Signaling · doi:10.1126/scisignal.aax3521 · Cited by 29
Pharmacological Activation of cGAS for Cancer Immunotherapy
Garland, K. M., Rosch, J. C., Carson, C. S., Wang-Bishop, L., Hanna, A., Sevimli, S., Kaer, C. V., Balko, J. M., Ascano, M., & Wilson, J. T. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.753472 · Cited by 27
Self-citationAIM2 inhibits autophagy and IFN-β production during M. bovis infection
Liu, C., Yue, R., Yang, Y., Cui, Y., Yang, L., Zhao, D., & Zhou, X. (2016) · Oncotarget · doi:10.18632/oncotarget.10503 · Cited by 26
Bukhalid, R. A., Duvall, J. R., Cetinbas, N. M., Catcott, K. C., Avocetien, K., Bentley, K. W., Bradley, S. P., Carter, T., Chin, C., Clardy, S. M., et al. (2020) · Cancer Research · doi:10.1158/1538-7445.am2020-6706 · Cited by 26
Engineering Vaccines for Tissue‐Resident Memory T Cells
Knight, F. C., & Wilson, J. T. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202000230 · Cited by 26
Self-citationIbrahim, K., Schommer, J. C., Morisky, D. E., Rodríguez, R., Gaither, C. A., & Snyder, M. (2021) · Pharmacy · doi:10.3390/pharmacy9010031 · Cited by 26
Duvall, J. R., Bukhalid, R. A., Cetinbas, N. M., Catcott, K. C., Slocum, K. L., Avocetien, K., Bentley, K. W., Bradley, S. P., Clardy, S. M., Collins, S. D., et al. (2021) · Cancer Research · doi:10.1158/1538-7445.am2021-1738 · Cited by 25
Li, H., Wang, J., Wang, J., Cao, L., Wang, Z., & Jia-wei, W. (2013) · Acta Crystallographica Section F Structural Biology Communications · doi:10.1107/s2053230x1303135x · Cited by 24
CD11c-targeted Delivery of DNA to Dendritic Cells Leads to cGAS- and STING-dependent Maturation
Laursen, M. F., Christensen, E., Degn, L. L. T., Jønsson, K. L., Jakobsen, M. R., Agger, R., & Kofod‐Olsen, E. (2017) · Journal of Immunotherapy · doi:10.1097/cji.0000000000000195 · Cited by 24
Small Molecule NF-κB Inhibitors as Immune Potentiators for Enhancement of Vaccine Adjuvants
Moser, B., Escalante-Buendia, Y., Steinhardt, R. C., Rosenberger, M. G., Cassaidy, B., Naorem, N., Chon, A. C., Nguyen, M. C., Tran, N., & Esser-Kahn, A. P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.511513 · Cited by 23
Nguyen, D. C., Shae, D., Pagendarm, H. M., Becker, K. W., Wehbe, M., Kilchrist, K. V., Pastora, L. E., Palmer, C. R., Seber, P., Christov, P. P., et al. (2020) · Advanced Healthcare Materials · doi:10.1002/adhm.202001056 · Cited by 23
Self-citationCytosolic sensing of aberrant DNA: arming STING on the endoplasmic reticulum
Wang, Q., Liu, X., Zhou, Q., & Wang, C. (2015) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2015.1067303 · Cited by 22
Deen, N. N. A., Haidar, M. A., & Talhouk, R. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00192 · Cited by 21
STING Activation and its Application in Immuno-Oncology
Lian, Y., Duffy, K. J., & Yang, J. (2019) · Current Topics in Medicinal Chemistry · doi:10.2174/1568026619666191010155903 · Cited by 21
Tansakul, M., Thim-uam, A., Saethang, T., Makjaroen, J., Wongprom, B., Pisitkun, T., & Pisitkun, P. (2020) · Frontiers in Immunology · doi:10.3389/fimmu.2020.01101 · Cited by 21
Verrier, E. R., & Langevin, C. (2021) · Frontiers in Immunology · doi:10.3389/fimmu.2021.637399 · Cited by 20
Ryuke, Y., Mizuno, M., Natsume, A., Suzuki, O., Nobayashi, M., Kageshita, T., Matsumoto, K., Saida, T., & Yoshida, J. (2003) · Melanoma Research · doi:10.1097/00008390-200308000-00003 · Cited by 19
Covarrubias, G., Moon, T. J., Loutrianakis, G., Sims, H. M., Umapathy, M. P., Lorkowski, M. E., Bielecki, P. A., Wiese, M. L., Atukorale, P. U., & Karathanasis, E. (2021) · Journal of Materials Chemistry B · doi:10.1039/d1tb02256c · Cited by 18
Degree of STING activation is associated with disease outcomes
Hu, Q., Wu, J., Ren, Y., Wu, X., Gao, L., Wang, G., Gu, G., Ren, H., Hong, Z., Slade, D. A. J., et al. (2019) · Gut · doi:10.1136/gutjnl-2019-318597 · Cited by 16
Banerjee, M., Basu, S., Middya, S., Shrivastava, R., Ghosh, R., Pryde, D. C., Yadav, D. B., Bhattacharya, G., Soram, T., Puniya, K., et al. (2019) · Cancer Research · doi:10.1158/1538-7445.am2019-lb-061 · Cited by 15
Engineering the Immune Adaptor Protein STING as a Functional Carrier
Sun, X., Ni, Y., He, Y., Yang, M., Tani, T., Kitajima, S., Barbie, D. A., & Li, J. (2021) · Advanced Therapeutics · doi:10.1002/adtp.202100066 · Cited by 15
Zheng, M., Xie, L., Liang, Y., Wu, S., Xu, H., Zhang, Y., Liu, H., Lin, D., Han, J., & Lu, K.-P. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.10945 · Cited by 14
Trojan horses for immunotherapy
Hubbell, J. A., & Swartz, M. A. (2019) · Nature Nanotechnology · doi:10.1038/s41565-019-0380-7 · Cited by 14
Abstract 3787: Exploring the effect of chemotherapies on STING-dependent cytokine release
Wilkinson, R. D. A., Johnston, D. I., Parkes, E. E., McCabe, N., & Kennedy, R. D. (2018) · Cancer Research · doi:10.1158/1538-7445.am2018-3787 · Cited by 4
Cited by
Radiotherapy combined with immunotherapy: the dawn of cancer treatment
Zhang, Z., Liu, X., Chen, D., & Yu, J. (2022) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-022-01102-y · Cited by 670
Role of the cGAS–STING pathway in systemic and organ-specific diseases
Skopelja-Gardner, S., An, J., & Elkon, K. B. (2022) · Nature Reviews Nephrology · doi:10.1038/s41581-022-00589-6 · Cited by 307
PANoptosis: Mechanisms, biology, and role in disease
Sun, X., Yang, Y., Meng, X., Li, J., Liu, X., & Liu, H. (2024) · Immunological Reviews · doi:10.1111/imr.13279 · Cited by 305
Metadata
- Authors
- Garland, K. M., Sheehy, T. L., & Wilson, J. T.
- Venue
- Chemical Reviews
- Publisher
- American Chemical Society (ACS)
- Published
- 2022-02-02
- Volume
- 122
- Issue
- 6
- Pages
- 5977-6039
- ISSN
- 0009-2665 (ISSN-L)
- 1520-6890
- OpenAlex
- W4210772725
- Cited by
- 357
- References
- 552
- FWCI
- 6.52
- Type
- journal article
- Language
- en
- Open access
- green
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.